Nanobac Pharmaceuticals, Inc. (NNBP)
0.0000
0.00 (0.00%)
USD |
OTCM |
Sep 08, 16:00
Nanobac Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2007 | -2.152 |
| September 30, 2007 | -2.260 |
| June 30, 2007 | -4.298 |
| March 31, 2007 | -12.38 |
| December 31, 2006 | |
| September 30, 2006 | -14.25 |
| June 30, 2006 | 15.69 |
| March 31, 2006 | 3.377 |
| December 31, 2005 | 1.008 |
| September 30, 2005 | 0.016 |
| June 30, 2005 | 0.3861 |
| March 31, 2005 | 0.0156 |
| December 31, 2004 | 0.042 |
| September 30, 2004 | 0.0044 |
| June 30, 2004 | 2.602 |
| March 31, 2004 | 1.602 |
| Date | Value |
|---|---|
| December 31, 2003 | -4.954 |
| September 30, 2003 | 0.1342 |
| June 30, 2003 | 0.2208 |
| March 31, 2003 | 0.00 |
| December 31, 2002 | 0.00 |
| June 30, 2000 | -0.9457 |
| March 31, 2000 | -1.198 |
| December 31, 1999 | -1.099 |
| September 30, 1999 | -2.007 |
| June 30, 1999 | -2.587 |
| March 31, 1999 | -3.227 |
| December 31, 1998 | -3.726 |
| September 30, 1998 | -7.564 |
| June 30, 1998 | 18.44 |
| March 31, 1998 | 5.816 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Biocept, Inc. | -- |
| BT Bidco, Inc. | -- |
| Myriad Genetics, Inc. | 0.6927 |
| Response Genetics, Inc. | -- |
| BioRestorative Therapies, Inc. | 0.0114 |